Swedish Orphan Biovitrum Ab (publ)

(OTC) BIOVF

Current Price$47.48

Market Cap$16.42B

Since IPO (2013)+379%

5 Year+166%

1 Year+56%

1 Month+19%

Swedish Orphan Biovitrum Ab (publ) Financials at a Glance

Market Cap

$16.42B

Revenue (TTM)

$28.88B

Net Income (TTM)

$936.33M

EPS (TTM)

$0.29

P/E Ratio

158.62

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$47.48

Volume

Open

$47.48

Price

$47.48

Volume

Open

$47.48

Previous Close

$47.48

Daily Range

$47.48 - $47.48

52-Week Range

$27.06 - $47.48

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$47.48

Volume

Open

$47.48

Previous Close

$47.48

Daily Range

$47.48 - $47.48

52-Week Range

$27.06 - $47.48

BIOVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Swedish Orphan Biovitrum Ab (publ)

Industry

Biotechnology

Sector

Health Care

Employees

1,969

CEO

Guido Oelkers, PhD

Website

www.sobi.com

Headquarters

Solna, 112 76, SE

BIOVF Financials

Key Financial Metrics (TTM)

Gross Margin

44%

Operating Margin

30%

Net Income Margin

Return on Equity

Return on Capital

14%

Return on Assets

Earnings Yield

0.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.42B

Shares Outstanding

345.85M

Volume

Avg. Volume

17.016

Financials (TTM)

Gross Profit

$12.29B

Operating Income

$8.03B

EBITDA

$10.94B

Operating Cash Flow

$8.54B

Capital Expenditure

$39.90M

Free Cash Flow

$8.50B

Cash & ST Invst.

$1.04B

Total Debt

$11.72B

Swedish Orphan Biovitrum Ab (publ) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$7.18B

+11.1%

Gross Profit

$5.44B

+11.5%

Gross Margin

75.69%

N/A

Market Cap

$16.42B

N/A

Market Cap/Employee

$8.66M

N/A

Employees

1,895

N/A

Net Income

$1.32B

+50.6%

EBITDA

$2.65B

+15.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$18.12B

-39.1%

Accounts Receivable

$9.28B

+35.7%

Inventory

$5.08B

+30.8%

Long Term Debt

$7.91B

-21.0%

Short Term Debt

$11.15B

+177.9%

Return on Assets

1.13%

N/A

Return on Invested Capital

14.37%

N/A

Free Cash Flow

$872.00M

-61.8%

Operating Cash Flow

$1.13B

-50.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ERFSFEurofins Scientific SE

ERFSFEurofins Scientific SE$72.31-1.95%

CHJTFCSPC Pharmaceutical Group Limited

CHJTFCSPC Pharmaceutical Group Limited$1.05+0.00%

RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.

RCDTFRecordati Industria Chimica e Farmaceutica S.p.A.$58.75+5.14%

CSPCYCSPC Pharmaceutical Group Limited

CSPCYCSPC Pharmaceutical Group Limited$3.79+4.35%

ESALFEisai Co., Ltd.

ESALFEisai Co., Ltd.$28.00+0.00%

GIFLFGrifols, S.A.

GIFLFGrifols, S.A.$11.12+0.00%

ESAIYEisai Co., Ltd.

ESAIYEisai Co., Ltd.$6.50-2.48%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FUTUFutu

FUTUFutu$92.12-0.26%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.15+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.84+0.01%

HPQHP

HPQHP$25.05+0.14%

RGTIRigetti Computing

RGTIRigetti Computing$26.39+0.20%

NVDANvidia

NVDANvidia$216.82-0.01%

QBTSD-Wave Quantum

QBTSD-Wave Quantum$30.15+0.17%

Questions About BIOVF

What is the current price of Swedish Orphan Biovitrum Ab (publ)?

Swedish Orphan Biovitrum Ab (publ) is trading at $47.48 per share.

What is the 52-week range for Swedish Orphan Biovitrum Ab (publ)?

Over the past 52 weeks, Swedish Orphan Biovitrum Ab (publ) has traded between $27.06 and $47.48.

How much debt does Swedish Orphan Biovitrum Ab (publ) have?

As of the most recent reporting period, Swedish Orphan Biovitrum Ab (publ) reported total debt of $2.00B.

How much cash does Swedish Orphan Biovitrum Ab (publ) have on hand?

Swedish Orphan Biovitrum Ab (publ) reported $98.67M in cash and cash equivalents in its most recent financial results.

What is Swedish Orphan Biovitrum Ab (publ)’s dividend yield?

Swedish Orphan Biovitrum Ab (publ) does not currently have a dividend yield.

Swedish Orphan Biovitrum Ab (publ)

Swedish Orphan Biovitrum Ab (publ) Financials at a Glance

BIOVF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Swedish Orphan Biovitrum Ab (publ)

BIOVF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Swedish Orphan Biovitrum Ab (publ) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIOVF

What is the current price of Swedish Orphan Biovitrum Ab (publ)?

What is the 52-week range for Swedish Orphan Biovitrum Ab (publ)?

How much debt does Swedish Orphan Biovitrum Ab (publ) have?

How much cash does Swedish Orphan Biovitrum Ab (publ) have on hand?

What is Swedish Orphan Biovitrum Ab (publ)’s dividend yield?

Premium Investing Services